Cargando…

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes

The gut microbiota has been linked to the development of obesity and type 2 diabetes (T2D). The underlying mechanisms as to how intestinal microbiota may contribute to T2D are only partly understood. It becomes progressively clear that T2D is characterized by a chronic state of low-grade inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheithauer, Torsten P. M., Rampanelli, Elena, Nieuwdorp, Max, Vallance, Bruce A., Verchere, C. Bruce, van Raalte, Daniël H., Herrema, Hilde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596417/ https://www.ncbi.nlm.nih.gov/pubmed/33178196 http://dx.doi.org/10.3389/fimmu.2020.571731

Ejemplares similares

Pancreatic (18)F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls
por: Bakker, Guido J., et al.
Publicado: (2019)

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity
por: Bakker, Guido J., et al.
Publicado: (2021)

Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
por: Scheithauer, Torsten P. M., et al.
Publicado: (2021)

Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes
por: Habibe, Jayron J., et al.
Publicado: (2022)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
por: de Jonge, Patrick A., et al.
Publicado: (2022)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome
por: Koopen, Annefleur M., et al.
Publicado: (2021)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Causality of small and large intestinal microbiota in weight regulation and insulin resistance
por: Scheithauer, Torsten P.M., et al.
Publicado: (2016)

Neural control of redox response and microbiota-triggered inflammation in Drosophila gut
por: Fuse, Naoyuki, et al.
Publicado: (2023)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects
por: Bakker, Guido J., et al.
Publicado: (2019)

Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
por: Liu, Moyan, et al.
Publicado: (2022)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Gut Microbiota Composition Is Related to AD Pathology
por: Verhaar, Barbara J. H., et al.
Publicado: (2022)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

The Role of the Gut Microbiota in the Gut–Brain Axis in Obesity: Mechanisms and Future Implications
por: van Son, Jamie, et al.
Publicado: (2021)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions
por: Zwartjes, Max S. Z., et al.
Publicado: (2021)

Impact of the gut microbiota on inflammation, obesity, and metabolic disease
por: Boulangé, Claire L., et al.
Publicado: (2016)

Protocol for a double-blinded randomised controlled trial to assess the effect of faecal microbiota transplantations on thyroid reserve in patients with subclinical autoimmune hypothyroidism in the Netherlands: the IMITHOT trial
por: Fenneman, Aline C, et al.
Publicado: (2023)

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD
por: Meijnikman, Abraham S., et al.
Publicado: (2021)

Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts
por: Bel Lassen, Pierre, et al.
Publicado: (2021)

Peptidoglycan Recognition Protein 4 Limits Bacterial Clearance and Inflammation in Lungs by Control of the Gut Microbiota
por: Dabrowski, Alexander N., et al.
Publicado: (2019)

Microbiota Inhibit Epithelial Pathogen Adherence by Epigenetically Regulating C-Type Lectin Expression
por: Woo, Vivienne, et al.
Publicado: (2019)

Shedding light on dark matter – faecal microbiota transplantation in Europe
por: Wortelboer, Koen, et al.
Publicado: (2021)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Atractylodes macrocephala Koidz. volatile oil relieves acute ulcerative colitis via regulating gut microbiota and gut microbiota metabolism
por: Cheng, Hao, et al.
Publicado: (2023)

Abnormalities in Gut Microbiota and Metabolism in Patients With Chronic Spontaneous Urticaria
por: Wang, Xin, et al.
Publicado: (2021)

Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases
por: Wang, Lu, et al.
Publicado: (2022)

Editorial: Improve metabolic and autoimmune diseases by regulating gut microbiota
por: Kang, Yongbo, et al.
Publicado: (2022)

Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance
por: Munjoma, Privilege Tendai, et al.
Publicado: (2023)

Gut Microbiota in Hypertension and Atherosclerosis: A Review
por: Verhaar, Barbara J. H., et al.
Publicado: (2020)

Cranberry polyphenols and agave agavins impact gut immune response and microbiota composition while improving gut barrier function, inflammation, and glucose metabolism in mice fed an obesogenic diet
por: Medina-Larqué, Ana-Sofía, et al.
Publicado: (2022)

Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
por: Macpherson, Magnhild E., et al.
Publicado: (2020)

Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis
por: Saresella, Marina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ogf1uj21950i9amlfq337drvn7